AMBER DENAY CLINE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family BARBOURSVILLE, WV NPI 1154893576

General Payments — all program years on this page

$4,453.76

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 280
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $248.87 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $248.8716

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $103.466
Novo Nordisk AS $100.847
ABBVIE INC. $30.172
BOSTON SCIENTIFIC CORPORATION $14.401

By program year

Program yearAmountRecords
2021 $1,662.89114
2022 $1,981.34116
2023 $560.6634
2024 $248.8716

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087006044 Novartis Pharmaceuticals Corporation $17.05 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087006046 Novartis Pharmaceuticals Corporation $16.66 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087006048 Novartis Pharmaceuticals Corporation $13.87 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087006050 Novartis Pharmaceuticals Corporation $20.89 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087006052 Novartis Pharmaceuticals Corporation $18.21 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087006054 Novartis Pharmaceuticals Corporation $16.78 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092350291 Boston Scientific Corporation $14.40 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100261809 Novo Nordisk Inc $13.83 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100300925 Novo Nordisk Inc $13.36 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100339988 Novo Nordisk Inc $13.82 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100387191 Novo Nordisk Inc $19.75 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100416553 Novo Nordisk Inc $13.36 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100599283 Novo Nordisk Inc $13.36 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100629322 Novo Nordisk Inc $13.36 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107527515 ABBVIE INC. $16.82 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107527517 ABBVIE INC. $13.35 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.